Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma

Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) ranks fifth in occurrence and second in mortality of all cancers. The development of effective therapies for HCC is urgently needed. Anticancer drugs targeted to the liver-specific asialoglycoprotein receptors (ASGPRs) are viewed as a promising potential treatment for...

Full description

Bibliographic Details
Main Authors: Nayelli Guadalupe Teran-Saavedra, Jose Andre-i Sarabia-Sainz, Erika Silva-Campa, Alexel J. Burgara-Estrella, Ana María Guzmán-Partida, Gabriela Ramos-Clamont Montfort, Martín Pedroza-Montero, Luz Vazquez-Moreno
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Molecules
Subjects:
nanoparticles
BSA-lactosylate
HepG2 cell line
asialoglycoprotein receptor
Online Access:https://www.mdpi.com/1420-3049/24/7/1382

Internet

https://www.mdpi.com/1420-3049/24/7/1382

Similar Items